Skip to main content

Research Repository

Advanced Search

All Outputs (3)

Convergent genetic and expression data implicate immunity in Alzheimer's disease (2014)
Journal Article
Bossù, P., Tsuang, D. W., Lleò, A., Wallon, D., Todd, S., Dufouil, C., …Holmans, P. (2015). Convergent genetic and expression data implicate immunity in Alzheimer's disease. Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 11(6), 658-671. https://doi.org/10.1016/j.jalz.2014.05.1757

© 2015, Elsevier Inc. All rights reserved. Background: Late-onset Alzheimer's disease (AD) is heritable with 20 genes showing genome-wide association in the International Genomics of Alzheimer's Project (IGAP). To identify the biology underly... Read More about Convergent genetic and expression data implicate immunity in Alzheimer's disease.

The genetics of Alzheimer's disease: putting flesh on the bones (2014)
Journal Article
Medway, C., & Morgan, K. (2014). The genetics of Alzheimer's disease: putting flesh on the bones. Neuropathology and Applied Neurobiology, 40(2), https://doi.org/10.1111/nan.12101

For two decades the search for genes involved in Alzheimer's disease brought little reward; it was not until the advent of genome-wide association studies (GWAS) that genetic associations started to be revealed. Since 2009 increasingly large GWAS hav... Read More about The genetics of Alzheimer's disease: putting flesh on the bones.

Practical detection of a definitive biomarker panel for Alzheimer's disease: comparisons between matched plasma and cerebrospinal fluid (2014)
Journal Article
Richens, J. L., Vere, K., Light, R. A., Soria, D., Garibaldi, J., Smith, A. D., …O’Shea, P. (2014). Practical detection of a definitive biomarker panel for Alzheimer's disease: comparisons between matched plasma and cerebrospinal fluid. International Journal of Molecular Epidemiology and Genetics, IJMEG, 5(2),

Previous mass spectrometry analysis of cerebrospinal fluid (CSF) has allowed the identification of a panel of molecular markers that are associated with Alzheimer’s disease (AD). The panel comprises Amyloid beta, Apolipoprotein E, Fibrinogen alpha ch... Read More about Practical detection of a definitive biomarker panel for Alzheimer's disease: comparisons between matched plasma and cerebrospinal fluid.